Otsuka Beijing Research Institute
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Subsidiary
- Established
- 2003-08-29
- Employees
- -
- Market Cap
- -
- Website
- http://www.obri.com.cn
Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-04-04
- Last Posted Date
- 2020-12-29
- Lead Sponsor
- Otsuka Beijing Research Institute
- Target Recruit Count
- 111
- Registration Number
- NCT03487770
- Locations
- 🇨🇳
6th affiliated hospital, Peking University, Beijing, Beijing, China
Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-04-04
- Last Posted Date
- 2020-12-29
- Lead Sponsor
- Otsuka Beijing Research Institute
- Target Recruit Count
- 121
- Registration Number
- NCT03487783
- Locations
- 🇨🇳
Beijing Anding Hospital of Capital Medical University, Beijing, Beijing, China
The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder
- First Posted Date
- 2018-04-03
- Last Posted Date
- 2020-12-29
- Lead Sponsor
- Otsuka Beijing Research Institute
- Target Recruit Count
- 65
- Registration Number
- NCT03487198
- Locations
- 🇨🇳
Beijing Anding Hospital of Capital Medical University, Beijing, Beijing, China
Aripiprazole IM Depot for Chinese Patients With Schizophrenia
- First Posted Date
- 2017-09-19
- Last Posted Date
- 2020-12-29
- Lead Sponsor
- Otsuka Beijing Research Institute
- Target Recruit Count
- 24
- Registration Number
- NCT03287505
- Locations
- 🇨🇳
Beijing Anding Hospital of Capital Medical University, Beijing, Beijing, China
PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia
- First Posted Date
- 2017-09-18
- Last Posted Date
- 2020-07-10
- Lead Sponsor
- Otsuka Beijing Research Institute
- Target Recruit Count
- 12
- Registration Number
- NCT03285503
- Locations
- 🇨🇳
Beijing Anding Hospital of Capital Medical University, Beijing, Beijing, China
Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-06-01
- Last Posted Date
- 2020-12-29
- Lead Sponsor
- Otsuka Beijing Research Institute
- Target Recruit Count
- 436
- Registration Number
- NCT03172871
- Locations
- 🇨🇳
Beijing Anding Hospital of Capital Medical University, Beijing, Beijing, China
A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy Volunteers
Not Applicable
Completed
- Conditions
- First Posted Date
- 2014-07-22
- Last Posted Date
- 2014-07-22
- Lead Sponsor
- Otsuka Beijing Research Institute
- Target Recruit Count
- 120
- Registration Number
- NCT02196805
- Locations
- 🇨🇳
Clinical Pharmacology Research Center Peking Union Medical College Hospital, Beijing, China
To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia Subject
- First Posted Date
- 2014-03-28
- Last Posted Date
- 2014-03-31
- Lead Sponsor
- Otsuka Beijing Research Institute
- Target Recruit Count
- 250
- Registration Number
- NCT02098460
- Locations
- 🇨🇳
Anzhen hospital, Beijing, China
Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema
- First Posted Date
- 2012-07-26
- Last Posted Date
- 2013-12-30
- Lead Sponsor
- Otsuka Beijing Research Institute
- Target Recruit Count
- 244
- Registration Number
- NCT01651156
- Locations
- 🇨🇳
Zhejiang Hospital, Hangzhou, Zhejiang, China
Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects
- First Posted Date
- 2012-05-03
- Last Posted Date
- 2013-06-05
- Lead Sponsor
- Otsuka Beijing Research Institute
- Target Recruit Count
- 12
- Registration Number
- NCT01590901
- Locations
- 🇨🇳
Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Beijing, China
© Copyright 2024. All Rights Reserved by MedPath